Clinical Trial Update: Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 crossover study evaluating the pharmacokinetics of ezogabine/retigabine in Taiwanese subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Ezogabine (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 1 | Status: COMPLETED